drug · small molecule
TUZISTRA XR
Marketedupdated 2mo agoby $TRAW Traws Pharma, Inc.🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3Small molecule drug with a maximum clinical stage of Phase 1.
targets
Histamine H1 receptor
all catalysts(9)
approval · 9
Apr 30, 2015
approval
$TRAW
TUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approval
TUZISTRA XR
→
Dec 4, 2015
approval
$TRAW
TUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approval
TUZISTRA XR
→
Feb 19, 2016
approval
$TRAW
TUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approval
TUZISTRA XR
→
Jan 13, 2017
approval
$TRAW
TUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approval
TUZISTRA XR
→
Feb 17, 2017
approval
$TRAW
TUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approval
TUZISTRA XR
→
Aug 29, 2017
approval
$TRAW
TUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approval
TUZISTRA XR
→
Jun 28, 2018
approval
$TRAW
TUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approval
TUZISTRA XR
→
Dec 15, 2023
approval
$TRAW
TUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approval
TUZISTRA XR
→
Dec 22, 2025
approval
$TRAW
TUZISTRA XR (CHLORPHENIRAMINE POLISTIREX) — FDA approval
TUZISTRA XR
→
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 15, 2027
232 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Mar 29, 2029formulationUS 80626672.7y
- Mar 15, 2027formulationUS 8790700232d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that